Abstract
Since the announcement of the COVID-19 pandemic in March 2020, a large number of studies have been conducted indicating that coronavirus infection not only affects the lungs but also has a significant and prolonged negative impact on other organs and systems. For example, an association between coronavirus infection and myocarditis has been proven. Cardiac manifestations can vary and include myocarditis, life-threatening arrhythmias, acute coronary syndrome, systolic heart failure, and cardiogenic shock. The SARS-CoV-2 virus is also capable of directly damaging the pancreas, which can worsen the course of diabetes and even trigger the onset of autoimmune diabetes in individuals who were previously not diabetic. Diabetes, one of the most prevalent chronic diseases in the world, is strongly associated with a poor prognosis in the case of COVID-19.
Publisher
Ukrainian Diabetology Association
Reference15 articles.
1. Buzzetti R, Zampetti S, Maddaloni E. Adult-onset autoimmune diabetes: current knowledge and implications for management. Nat Rev Endocrinol. 2017;13(11):р.674-686.
2. Carlsson S. Etiology and Pathogenesis of Latent Autoimmune Diabetes in Adults (LADA) Compared to Type 2 Diabetes. Front Physiol. 2019;10:р.320.
3. Dandona P, Dhindsa S, Chaudhuri A, et al. Latent autoimmune diabetes in adults (LADA): diagnosis, prevalence, and clinical approach. Diabetes Voice. 2018;63(1):р.21-23.
4. Laugesen E, Østergaard JA, Leslie RD., Danish Diabetes Academy Workshop and Workshop Speakers. Latent autoimmune diabetes of the adult: current knowledge and uncertainty. Diabet Med. 2015 Jul;32(7):р. 843-52
5. Bornstein SR, Rubino F, Khunti K, et al. Practical recommendations for the management of diabetes in patients with COVID-19. Lancet Diabetes Endocrinol. 2020;8(6):р.546-550.